032. Moxifloxacin pharmacokinetics in patients with lung infection from 
non-tuberculous mycobacteria

BACKGROUND: Lung infection from non-tuberculous mycobacteria (NTM), represent a significant clinical problem due to its increased incidence and difficult management. Moxifloxacin (MXF) can play an important role in the treatment of these infections, especially when microbial resistance is an issue....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Dis
Autori principali: Manika, Katerina, Chatzika, Kalliopi, Kipourou, Maria, Lada, Martha, Zarogoulidis, Konstantinos, Kioumis, Ioannis
Natura: Artigo
Lingua:Inglês
Pubblicazione: AME Publishing Company 2015
Soggetti:
The Pan Hellenic Congress Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332104/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB032
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi